On January 22, LIVZON PHARMA (01513) spent 117.54 million yuan to repurchase 326,000 A shares.

date
22/01/2025
avatar
GMT Eight
LIVZON PHARMA (01513) announced that it will spend 117.54 million RMB to repurchase 326,000 A shares on January 22, 2025.
pre
HG SEMI(06908): The subscription rate for the rights issue is approximately 74.74%
CHINARES PHARMA(03320): China Resources Boya Bio-pharmaceutical Group(300294.SZ) expects the net profit attributable to the parent company to increase by about 380-480 million yuan in 2024 compared to the previous year.
next

RECOMMEND

recommend

Glodon (002410.SZ) issues a profit forecast, predicting that the net profit for the year 2024 will be between 2.2 billion and 2.6 billion yuan, an increase of 89.92% to 124.45%.

date
5 min ago
recommend

Grace Fabric Technology (603256.SH) has forecasted a net profit of 14.52 million to 21.77 million yuan for the year 2024, turning losses into gains.

date
10 min ago
recommend

Shenzhen Anche Technologies (300572.SZ) issues a profit warning, expecting a net loss of 170 million to 280 million yuan for the year.

date
10 min ago

©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.

Contact: contact@gmteight.com